Article info
PDFRheumatoid arthritis
Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial
- Correspondence to Dr Benjamin Burggraaf, Department of Internal Medicine, Center for Diabetes and Vascular Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, 3045 PM, The Netherlands; b.burggraaf{at}franciscus.nl
Citation
Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial
Publication history
- Received July 8, 2018
- Revised November 17, 2018
- Accepted November 26, 2018
- First published January 4, 2019.
Online issue publication
February 14, 2019
Article Versions
- Previous version (4 January 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.